Gary S. Gray
- Transplantation top 1%
- Immunology top 0.5%
- T-cell and B-cell Immunology 17
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 10
- Immunology and Allergy top 1%
- Virology top 2%
- Oncology top 2%
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Gordon J. FreemanVassiliki A. BoussiotisTheodore E. MaioneLee M. NadlerJohn G. GribbenLisa A. LombardDavid M. HarlanAllan D. Kirk
- Partner nations
- United StatesHungarySwitzerland
In The Last Decade
Gary S. Gray
36 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Transplantation 430
- Immunology 3.2k
- Immunology and Allergy 404
- Virology 263
- Oncology 1.0k
Countries citing papers authored by Gary S. Gray
This map shows the geographic impact of Gary S. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary S. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary S. Gray more than expected).
Fields of papers citing papers by Gary S. Gray
This network shows the impact of papers produced by Gary S. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary S. Gray. The network helps show where Gary S. Gray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary S. Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 1 | |
| 2 | 2005 | 31 | |
| 3 | Targeted therapy for cancer: the HER-2/neu and Herceptin story. | 2004 | 26 |
| 4 | 2003 | 37 | |
| 5 | 2002 | 51 | |
| 6 | 2001 | 108 | |
| 7 | 1999 | 52 | |
| 8 | 1999 | 11 | |
| 9 | 1999 | 59 | |
| 10 | 1998 | 162 | |
| 11 | 1998 | 107 | |
| 12 | 1998 | 19 | |
| 13 | 1996 | 40 | |
| 14 | 1995 | 143 | |
| 15 | 1994 | 333 | |
| 16 | 1993 | 38 | |
| 17 | 1991 | 15 | |
| 18 | 1990 | 68 | |
| 19 | 1989 | 11 | |
| 20 | 1989 | 331 |
About Gary S. Gray
Gary S. Gray is a scholar working on Immunology, Transplantation and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 5.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers), CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Transplantation (430 citations), Immunology (3.2k citations) and Immunology and Allergy (404 citations). Gary S. Gray has collaborated with scholars based in United States, Hungary and Switzerland. Frequent co-authors include Gordon J. Freeman, Vassiliki A. Boussiotis, Theodore E. Maione, Lee M. Nadler, John G. Gribben, Lisa A. Lombard, David M. Harlan, Allan D. Kirk, Stuart J. Knechtle and Nicholas Armstrong. Their work appears in journals such as Transplantation, The Journal of Immunology, Science, Gene and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.